An observational study in Depression and Anxiety, sponsored by Massachusetts General Hospital. Completed. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2016-05-17.
Sponsored by Massachusetts General Hospital · Observational
The purpose of this study is to assess the effectiveness of a Relaxation Response Intervention for Depression offered to low income populations at Massachusetts General Hospital (MGH) - Chelsea, Revere and Charlestown health centers.
This is a retrospective review of medical records. The study aims to evaluate the effects of participation in the Relaxation Response Intervention for Depression Clinical groups, on patient measures of: 1) depression, anxiety and perceived stress; 2) work productivity and activity impairment; 3) demand for, and adherence to behavioral medicine; 4) medication use for depression and/or anxiety; and 5) dose-response effects.
8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.
This study's enrollment of 156 is close to the median of 160 across 1,084 observational studies indexed under Depression.
Browse Depression studies →Massachusetts General Hospital is the lead sponsor of 2,536 studies on the registry; 446 are open to participants now.
Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.
Counted across the registry records on this site, refreshed daily.
MGH-Health Center patients who have participated in the Relaxation Response Intervention for Depression groups.
Exclusion Criteria:
-
Change from baseline in Depression scales (CES-D 10) at 8 weeks
Time frame: Pre- and Post-Intervention (8 weeks)
Change from baseline Anxiety Scales (STAI-20) at 8 weeks
Time frame: Pre- and Post- Intervention (8 weeks)
Change from baseline in Perceived Stress Scale (PSS-10) at 8 weeks
Time frame: Pre- and Post-Intervention (8 weeks)
No study locations are listed for this record.
This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Massachusetts General Hospital